Purpose: To evaluate the utility of different optical coherence tomography angiography scan protocols in evaluating retinal changes in non-proliferative diabetic retinopathy.
D
iabetic retinopathy is a leading cause of vision loss, as well as the fifth most common cause of preventable blindness worldwide. 1, 2 Although in Type 1 diabetic patients, proliferative diabetic retinopathy (PDR) remains the most common cause of severe vision loss, diabetic macular edema (DME) is the most common cause of vision loss in Type 2 diabetic patients. 3 Thus, non-PDR is an important condition to monitor and manage in diabetic patients.
Traditionally, patients with PDR were monitored with serial fundus ophthalmoscopy in conjunction with ancillary testing, including fluorescein angiography (FA) to assess for areas of neovascularization of the disk or elsewhere, retinal edema, and nonperfusion. Although FA remains a gold-standard adjunctive test, it requires the injection of dye and is, therefore, not suitable for all patients, including those who have poor venous access and allergy to fluorescein (which may include anaphylaxis). 4, 5 With the advent of optical coherence tomography (OCT), and more recently, OCT angiography (OCTA), it is now possible to assess the anatomy and integrity of the retinal and choroidal vasculature rapidly and noninvasively. 4, [6] [7] [8] It has been used to evaluate a variety of pathologies ranging from neovascular age-related macular degeneration, [9] [10] [11] vein occlusions 12, 13 to central serous chorioretinopathy. [14] [15] [16] Optical coherence tomography angiography uses the principle of speckle decorrelation to measure the difference in backscattered OCT signals between sequential B scans taken at the same location to generate angiographic images. 17 Because OCTA is still a relatively new imaging technique, studies are needed to elucidate the different findings in these conditions and to confirm the sensitivity and specificity of the pathologies. In addition, there is currently no industry standard for the image size of the OCTA enface image and their scan density. For example, the RTVue XR Avanti OCTA (Optovue, Inc, Fremont, CA) has three scan protocols (3 · 3 mm, 6 · 6 mm, and 8 · 8 mm). Each scan protocol consists of 304 · 304 B scans. Thus, the purpose of this study is to compare 2 commercially available OCT A scan protocols-the 3 mm · 3 mm and 6 mm · 6 mm scans-in the detection of various pathologies that may be seen in patients with non-PDR.
Methods

Subjects and Optical Coherence Tomography Angiography Scan Protocols
Patients with history of mild-to-severe non-PDR seen at the vitreoretinal service at Shiley Eye Institute, University of California, San Diego between July and December 2015 were eligible. The study was approved by the University of California, San Diego Review Board and was conducted in accordance with the ethical standards stated in the 1964 Declaration of Helsinki. Patients with evidence of significant anterior segment, media opacities, and optic nerve or retinal pathologies other than non-PDR were excluded from the study. The severity of PDR was graded based on the International Clinical Diabetic Retinopathy Severity Scale. 18 In addition, patients with high myopia or evidence of pathological myopia, including posterior staphyloma or choroidal neovascularization were excluded. Fluorescein angiography was not routinely obtained for patients imaged. However, in instances of severe non-PDR, fluorescein angiography was obtained to rule out the presence of proliferative disease.
Patients were imaged using the RTVue XR Avanti OCT A 3 mm · 3 mm and 6 mm · 6 mm "Angio Retina" scan protocols ( Figure 1 ). Two scans from each eye were obtained for each protocol. The scan with the higher signal strength of the two was selected. When both scans from a protocol had the same signal strength, one scan was selected at random for analysis. All scans had a signal strength of at least 50 of 100. Both eyes from each patient were imaged and both eyes were included in the study if they both met the inclusion criteria. 
Image Analysis
Each OCT A scan was individually analyzed on the Avanti OCT On-screen computer display by a grader (J.H.). Each individual B scan was analyzed for the presence of DME affecting the evaluation of the OCTA image and excluded if present. In addition, scans with edema around the foveal avascular zone (FAZ) were also excluded. The superficial retina scan slab, segmented at the superficial capillary plexus at the ganglion cell layer, was selected for analysis as it could most readily identify the extent of the FAZ. The presence or absence of each of the features or artifacts was compared using the McNemar chi-square test. All statistical analyses were performed using Microsoft Excel (Microsoft Corp, Redmond, WA).
Results
A total of 46 eyes from 27 patients were enrolled in this study. Average age of the patients was 63 (SD 11) -13 of whom were females and 14 were males. Thirty-eight eyes had mild, four eyes had moderate, and four with severe non-PDR. Five eyes demonstrated non-FAZ DME on the OCT B scans.
Of the 27 patients in this study, 22 had a history of hypertension, 16 had hyperlipidemia, 2 patients were current smokers, and 10 were former smokers. Five had concurrent renal dysfunction. Hemoglobin A1C data were available for 23 patients, the average was 6.8%.
Analysis of Optical Coherence Tomography Angiography Features
Eighty-nine percent (41/46) of the 3 mm · 3 mm scans clearly demonstrated the extent of the FAZ, compared with 59% (27/46) of the 6 mm · 6 mm scans (P = 0.001; Table 1 ). Foveal avascular zone remodeling was seen in 80% (37/46) of the 3 mm · 3 mm images, compared with 43% (20/46) of the 6 mm · 6 mm scans (P = 0.0002). Microaneurysms were detected by 57% (26/46) of the 6 mm · 6 mm and 35% (16/46) of the 3 mm · 3 mm scans (P = 0.003). The presence of capillary nonperfusion was similar between the 2 groups: 87% (40/46) of the 3 mm · 3 scans versus 89% (41/46) of the 6 mm · 6 mm scans (P = 0.99).
Error Analysis
In terms of the incidence of motion artifacts, it was seen in 13% (6/46) of 3 mm · 3 mm scans and 20% (9/ 46) of 6 mm · 6 mm scans. The difference was not statistically significant (P = 0.29). Twenty-two percent (10/46) of the 3 mm · 3 mm scans and 13% (6/46) of the 6 mm · 6 mm scans showed doubling artifacts. There were no significant differences noted in the incidence of this error (P = 0.29).
Discussion
This study demonstrated that there were significant differences noted in the prevalence of the various pathologies seen in patients with non-PDR between the two OCT A scan sizes. The 3 mm · 3 mm scans more clearly delineated the extent of the FAZ as well as remodeling of the FAZ compared with the 6 mm · 6 mm scans. The 6 mm · 6 mm scans more clearly demonstrated the presence of MAs compared with the 3 mm · 3 mm scans. Both 3 mm · 3 mm as well as the 6 mm · 6 mm scans showed similar incidence of capillary nonperfusion. In addition, both scan protocols showed similar incidences of motion and doubling artifacts.
The RTVue XR Avanti has a scan rate of 70,000 A scans per second with a 5-mm axial and 15-mm transverse resolution. It acquires scans consisting of 304 · 304 B scans (304 A scans per line) with 2 repeats, which are then averaged. It has the options of 3 mm · 3 mm, 6 mm · 6 mm, and 8 mm · 8 mm scan sizes (with each protocol taking about 3 seconds). Because all scan protocols, regardless of the scan volume, consists of 304 · 304 B scans, the scan density for the 3 mm · 3 mm is higher than that for the 6 mm · 6 mm scans. Thus, given the higher image resolution of the 3 mm · 3 mm compared with the 6 mm · 6 mm scans, it is intuitive that the 3 mm · 3 mm protocol more clearly delineates findings like the clarity of the FAZ extent as well as remodeling of the FAZ. Carpineto et al 19 used the 3 mm · 3 mm scan protocol and showed that FAZ measurements were both reproducible and repeatable in normal eyes. Takase et al 20 also demonstrated that the 3 mm · 3 mm OCT A scans were able to delineate the extent of the FAZ and showed enlargement in eyes with diabetic retinopathy. These studies both selected the 3 mm · 3 mm scans over the other protocols, likely to take advantage of their higher scan density.
Ishibazawa et al 21 demonstrated that MAs could be clearly delineated with a 3 mm · 3 mm protocol in a pilot study using the RTVue XR Avanti. This study showed that the 6 mm · 6 mm scans were more likely to pick up MAs. This was likely because a scan protocol with a wider area of coverage such as the 6 mm · 6 mm was more likely to show the presence of more diffuse or scattered pathologies like MAs.
Spaide et al 22 discussed various imaging artifacts that may occur with OCTA. The authors discussed that motion artifacts may be the result of ocular saccades, and thus, one way to decrease this incidence was to acquire dual OCT B scans, one horizontally and another vertically. Then, the software corrected for motion artifacts by estimating and translating the eye motion for each A scan and subsequently comparing the volumes. The utilization of software correction could introduce other imaging artifacts such as doubling artifacts. The incidence of motion and doubling artifacts was clinically assessed in this study. We found that they were not significantly different between the protocols because the scan acquisition time was similar for both scans. The presence of both artifacts was relatively high. This illustrates that further research will be necessary to increase scan speeds to decrease the incidence of motion artifacts, and improvements to the software will also be needed to decrease the prevalence of doubling artifacts.
In this study, only retinal changes in the superficial capillary plexus were evaluated. Although retinopathy may affect both superficial as well as the deep capillary plexus in diabetic patients, we focused on the superficial plexus in this study because we could more readily identify the pathologies. Ishibazawa et al 21 evaluated OCTA images in patients with PDR in both the superficial as well as the deep capillary plexus using 3 mm · 3 mm OCT A scans. They observed that areas of retinal nonperfusion were greater in the superficial than in the deep capillary plexus and suggested that the deep capillaries could be relatively more spared compared with capillaries in the superficial plexus secondary to anatomical differences. A potential future study could be to do a comparative study looking at 3 mm · 3 mm versus 6 mm · 6 mm scan sizes to evaluate MAs, FAZs, and capillary nonperfusion status in the deep capillary plexus. We suspect the results would be similar to the current study as FAZ remodeling would still benefit from the higher scan resolution of a 3 mm · 3 mm scan and MA identification would benefit from the wider field of view of a 6 mm · 6 mm scan.
Limitations of the study include the absence of FA to compare with OCTA images. de Carlo et al compared the incidence of MAs on OCTA versus FA and found that although OCTA was able to visualize most of the MAs seen on FA, some MAs were only noted on OCTA and not on FA, and vice versa. 2, 17 Thus, future studies may be necessary to compare the sensitivity and specificity of OCTA versus FA findings. Because this study only analyzed data obtained from RTVue XR Avanti, another possible future direction would be a comparison of the various OCT A devices, such as the Zeiss Cirrus HD-OCT Model 5000 with Angioplex OCTA capability (which uses a spectral domain OCT with a scan rate of 68,000 A scans/second with scans consisting of 350 · 350 A scans). 23 Because this study only evaluated the presence versus absence of different retinal findings, another potential future study could be to quantitatively assess pathologies such as actual number or MAs or volume of capillary nonperfusion measured using the different OCT A scan protocols. Another limitation of the study is the presence of DME in five eyes, which may interfere with the detection of features such as MAs and FAZ measurements. However, we have correlated the OCT B scans with the OCT A scans and the presence of DME in our patients did not seem to have affected the quality of the images. This study only evaluated OCT A scans at the level of the superficial capillary plexus, and thus, this may miss potential retinal changes that may occur at other locations, such as in the deep capillary plexus. In this study, the grader was not masked as to the relative size of the image being graded (3 mm · 3 mm or 6 mm · 6 mm) because the purpose of this study was to evaluate the scans under real-world, standard clinical conditions, and as such, masking would be difficult logistically because the scan size could be recognized by the reader. However, this is another potential limitation to the study, especially when evaluating central findings such as FAZ remodeling or delineation. Another limitation was the inclusion of two eyes in some patients and one eye in other patients. Last, only one observer was used to evaluate the OCT scans; thus, this may also be a potential source of bias. This study demonstrated that there was clinical utility for both the higher scan resolution obtainable with a smaller (3 mm · 3 mm) scan, as well as the larger field of view obtained with a larger (6 mm · 6 mm) OCT A scan protocols in assessing patients with non-PDR. Given the relatively quick scan acquisition time (approximately 3 seconds), it would be both clinically feasible and helpful to obtain and analyze both scans in the care of these patients.
